The global mRNA Vaccine and Therapeutics market gained a market size of nearly USD 587.5 million in 2020 and is estimated to reach 2911.8 million in 2027 with a CAGR of 28.4 % during the forecast period.
Global mRNA Vaccine and Therapeutics Market, 2020 – 2027 (USD Million)
mRNA vaccines are the advanced type of vaccine designed to generate immunity against infectious diseases. Many vaccines use inactivated or weakened form of the pathogen to trigger the immune response in the body. However, mRNA vaccines program cell to make a protein or even just a part of a protein which can induce an immune response against pathogens. With the advanced research many biological drug manufacturers are focusing on producing mRNA vaccines owing to their high efficiency.
Key Trends in Global Market
Increasing research on mRNA vaccines
mRNA vaccines are tested highly efficient for generating immune response in the human body. Also, the immunity generated by mRNA vaccines stays for long period of time. Owing to such advantages many bio-pharmaceutical companies are focusing on developing mRNA vaccines for deadly diseases. In addition, current COVID-19 pandemic also spurred the demand of mRNA vaccines and therapeutic. Many pharma majors such Pfizer-BioNTech and the Moderna have already developed mRNA vaccines for COVID-19, and many other market players are focusing to invest high amount for the development of mRNA-based vaccines.
Browse the full report at https://www.credenceresearch.com/report/mrna-vaccine-and-therapeutics-market
Global Market by Vaccine Type Insights
mRNA vaccine and therapeutic are primarily categorized as self-amplifying mRNA-based vaccines and conventional non-amplifying mRNA-based vaccines in this market. Owing to high efficiency of self-amplifying mRNA-based vaccines over other types of mRNA vaccines demand for self-amplifying mRNA vaccines is more. Which is also mainly causing the large share of the segment in overall market.
Global Market by Application Insights
Applications of mRNA vaccine and therapeutics are categorized as cancer, infectious disease, and other in the global market. infectious disease segment holds the largest share of the market owing to high prevalence of infectious disease worldwide. For instance, current COVID-19 pandemic has created huge demand for mRNA vaccine and therapeutic worldwide.
Global Market by Regional Insights
North America is the largest market for mRNA vaccine and therapeutics. The region expected to remain major revenue contributor for mRNA vaccine and therapeutics market over the forecast period. Presence of major bio-pharma players, and high investments on research for development of mRNA vaccines is primarily contributing to the major share of the market in this region.
Global Market Competitive Landscape
Some of the market players with a large share in the global market include Pfizer Inc., Arcturus Therapeutics Inc., Moderna Therapeutics Inc., BioNTech SE, CureVac AG, Etherna, ethris GmbH, Translate Bio Inc., GlaxoSmithKline PLC, Argos Therapeutics, Inc., Sangamo Therapeutics Inc. The report covers very detailed profiles of these key players.
Market Segmentation
Global mRNA Vaccine and Therapeutics Market by Vaccine Type, 2015 – 2027
· Self-amplifying mRNA-based Vaccines
· Conventional Non-Amplifying mRNA-Based Vaccines
Global mRNA Vaccine and Therapeutics Market by Application, 2015 – 2027
· Cancer
· Infectious Disease
· Others
Global mRNA Vaccine and Therapeutics Market by End User, 2015 – 2027
· Hospitals and Clinics
· Research Organizations
· Other End-User
Global mRNA Vaccine and Therapeutics Market by Region, 2015 – 2027
· North America
· Europe
· Asia Pacific
· Latin America
· Middle East and Africa
Global mRNA Vaccine and Therapeutics Market: Key Players
· Pfizer Inc.
· Arcturus Therapeutics Inc.
· Moderna Therapeutics Inc.
· BioNTech SE
· CureVac AG
· Etherna
· ethris GmbH
· Translate Bio Inc.
· GlaxoSmithKline PLC
· Argos Therapeutics, Inc.
· Sangamo Therapeutics Inc.
ToC:
Table of Content1.Preface1.1.Report Description1.1.1.Purpose of the Report1.1.2.Target Audience1.1.3.USP and Key Offerings1.2.Research Scope1.3.Research Methodology1.3.1.Phase I – Secondary Research1.3.2.Phase II – Primary Research1.3.3.Phase III – Expert Panel Review1.3.4.Approach Adopted1.3.4.1.Top-Down Approach1.3.4.2.Bottom-Up Approach1.3.5.Assumptions1.4.Market Segmentation
2.Executive Summary2.1.Market Snapshot: Global mRNA Vaccine and Therapeutics Market
3.Market Dynamics & Factors Analysis3.1.Introduction3.1.1. Global mRNA Vaccine and Therapeutics Market Value, 2015-2027, (US$ Mn)3.2.Market Dynamics3.2.1.Key Growth Trends3.2.2.Major Industry Challenges3.2.3.Key Growth Pockets3.3.Attractive Investment Proposition,20203.3.1.Vaccine Type3.3.2.Application3.3.3.End User3.3.4.Geography3.4.Porter’s Five Forces Analysis3.4.1.Threat of New Entrants3.4.2.Bargaining Power of Buyers/Consumers3.4.3.Bargaining Power of Suppliers3.4.4.Threat of Substitute Vaccine Types3.4.5.Intensity of Competitive Rivalry3.5.Value Chain Analysis
4.Market Positioning of Key Players, 20204.1.Company market share of key players, 20204.2.Top 6 Players4.3.Top 3 Players4.4.Major Strategies Adopted by Key Players
5.COVID 19 Impact Analysis5.1.Global mRNA Vaccine and Therapeutics Market Pre Vs Post COVID 19, 2019 – 20275.2.Impact on Import & Export5.3.Impact on Demand & Supply
6.North America6.1.North America mRNA Vaccine and Therapeutics Market, by Country, 2015-2027(US$ Mn)6.1.1.U.S.6.1.2.Canada6.1.3.Mexico6.2.North America mRNA Vaccine and Therapeutics Market, by Vaccine Type, 2015-2027(US$ Mn)6.2.1.Overview6.2.2.Self-amplifying mRNA-based Vaccines6.2.3.Conventional Non-Amplifying mRNA-Based Vaccines6.3.North America mRNA Vaccine and Therapeutics Market, by Application, 2015-2027(US$ Mn)6.3.1.Overview6.3.2.Cancer6.3.3.Infectious Disease6.3.4.Other Applications6.4.North America mRNA Vaccine and Therapeutics Market, by End User, 2015-2027(US$ Mn)6.4.1.Overview6.4.2.Hospitals and Clinics6.4.3.Research Organizations6.4.4.Other End Users
7.Europe7.1.Europe mRNA Vaccine and Therapeutics Market, by Country, 2015-2027(US$ Mn)7.1.1.UK7.1.2.France7.1.3.Germany7.1.4.Italy7.1.5.Russia7.1.6.Spain7.1.7.Belgium7.1.8.Netherland7.1.9.Austria7.1.10.Sweden7.1.11.Poland7.1.12.Denmark7.1.13.Switzerland7.1.14.Rest of Europe7.2.Europe mRNA Vaccine and Therapeutics Market, by Vaccine Type, 2015-2027(US$ Mn)7.2.1.Overview7.2.2.Self-amplifying mRNA-based Vaccines7.2.3.Conventional Non-Amplifying mRNA-Based Vaccines7.3.Europe mRNA Vaccine and Therapeutics Market, by Application, 2015-2027(US$ Mn)7.3.1.Overview7.3.2.Cancer7.3.3.Infectious Disease7.3.4.Other Applications7.4.Europe mRNA Vaccine and Therapeutics Market, by End User, 2015-2027(US$ Mn)7.4.1.Overview7.4.2.Hospitals and Clinics7.4.3.Research Organizations7.4.4.Other End Users
8.Asia Pacific8.1.Asia Pacific mRNA Vaccine and Therapeutics Market, by Country, 2015-2027(US$ Mn)8.1.1.China8.1.2.Japan8.1.3.South Korea8.1.4.India8.1.5.Australia8.1.6.New Zealand8.1.7.Taiwan8.1.8.Southeast Asia8.1.9.Central Asia8.1.10.Rest of Asia Pacific8.2.Asia Pacific mRNA Vaccine and Therapeutics Market, by Vaccine Type, 2015-2027(US$ Mn)8.2.1.Overview8.2.2.Self-amplifying mRNA-based Vaccines8.2.3.Conventional Non-Amplifying mRNA-Based Vaccines8.3.Asia Pacific mRNA Vaccine and Therapeutics Market, by Application, 2015-2027(US$ Mn)8.3.1.Overview8.3.2.Cancer8.3.3.Infectious Disease8.3.4.Other Applications8.4.Asia Pacific mRNA Vaccine and Therapeutics Market, by End User, 2015-2027(US$ Mn)8.4.1.Overview8.4.2.Hospitals and Clinics8.4.3.Research Organizations8.4.4.Other End Users
9.Latin America9.1.Latin America mRNA Vaccine and Therapeutics Market, by Country, 2015-2027(US$ Mn)9.1.1.Brazil9.1.2.Argentina9.1.3.Peru9.1.4.Chile9.1.5.Colombia9.1.6.Rest of Latin America9.2.Latin America mRNA Vaccine and Therapeutics Market, by Vaccine Type, 2015-2027(US$ Mn)9.2.1.Overview9.2.2.Self-amplifying mRNA-based Vaccines9.2.3.Conventional Non-Amplifying mRNA-Based Vaccines9.3.Latin America mRNA Vaccine and Therapeutics Market, by Application, 2015-2027(US$ Mn)9.3.1.Overview9.3.2.Cancer9.3.3.Infectious Disease9.3.4.Other Applications9.4.Latin America mRNA Vaccine and Therapeutics Market, by End User, 2015-2027(US$ Mn)9.4.1.Overview9.4.2.Hospitals and Clinics9.4.3.Research Organizations9.4.4.Other End Users
10.Middle East10.1.Middle East mRNA Vaccine and Therapeutics Market, by Country, 2015-2027(US$ Mn)10.1.1.UAE10.1.2.KSA10.1.3.Israel10.1.4.Turkey10.1.5.Iran10.1.6.Rest of Middle East10.2.Middle East mRNA Vaccine and Therapeutics Market, by Vaccine Type, 2015-2027(US$ Mn)10.2.1.Overview10.2.2.Self-amplifying mRNA-based Vaccines10.2.3.Conventional Non-Amplifying mRNA-Based Vaccines10.3.Middle East mRNA Vaccine and Therapeutics Market, by Application, 2015-2027(US$ Mn)10.3.1.Overview10.3.2.Cancer10.3.3.Infectious Disease10.3.4.Other Applications10.4.Middle East mRNA Vaccine and Therapeutics Market, by End User, 2015-2027(US$ Mn)10.4.1.Overview10.4.2.Hospitals and Clinics10.4.3.Research Organizations10.4.4.Other End Users
11.Africa11.1.Africa mRNA Vaccine and Therapeutics Market, by Country, 2015-2027(US$ Mn)11.1.1.South Africa11.1.2.Egypt11.1.3.Nigeria11.1.4.Rest of Africa11.2.Africa mRNA Vaccine and Therapeutics Market, by Vaccine Type, 2015-2027(US$ Mn)11.2.1.Overview11.2.2.Self-amplifying mRNA-based Vaccines11.2.3.Conventional Non-Amplifying mRNA-Based Vaccines11.3.Africa mRNA Vaccine and Therapeutics Market, by Application, 2015-2027(US$ Mn)11.3.1.Overview11.3.2.Cancer11.3.3.Infectious Disease11.3.4.Other Applications11.4.Africa mRNA Vaccine and Therapeutics Market, by End User, 2015-2027(US$ Mn)11.4.1.Overview11.4.2.Hospitals and Clinics11.4.3.Research Organizations11.4.4.Other End Users
12.Global12.1.Global mRNA Vaccine and Therapeutics Market, by Vaccine Type, 2015-2027(US$ Mn)12.1.1.Overview12.1.2.Self-amplifying mRNA-based Vaccines12.1.3.Conventional Non-Amplifying mRNA-Based Vaccines12.2.Global mRNA Vaccine and Therapeutics Market, by Application, 2015-2027(US$ Mn)12.2.1.Overview12.2.2.Cancer12.2.3.Infectious Disease12.2.4.Other Applications12.3.Global mRNA Vaccine and Therapeutics Market, by End User, 2015-2027(US$ Mn)12.3.1.Overview12.3.2.Hospitals and Clinics12.3.3.Research Organizations12.3.4.Other End Users
13.Company Profiles13.1.Pfizer Inc.13.2.Arcturus Therapeutics Inc.13.3.Moderna Therapeutics Inc13.4.BioNTech SE13.5.CureVac AG13.6.Etherna13.7.ethris GmbH13.8.Translate Bio Inc.13.9.GlaxoSmithKline PLC13.10.Argos Therapeutics, Inc.13.11.Sangamo Therapeutics Inc.
Related report: Foot and Mouth Disease (FMD) Vaccines Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026
Media ContactCompany Name: Credence ResearchContact Person: Chris SmithEmail: Send EmailPhone: 18003618290City: SAN JOSEState: CACountry: United StatesWebsite: https://www.credenceresearch.com/report/mrna-vaccine-and-therapeutics-market